Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib (Q83470965)
Jump to navigation
Jump to search
scientific article published on 23 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib |
scientific article published on 23 February 2011 |
Statements
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib (English)
Manabu Morimoto
Kazushi Numata
Masaaki Kondo
Hisashi Hidaka
Juichi Takada
Akitaka Shibuya
Satoshi Kobayashi
Shinichi Ohkawa
Chiaki Okuse
Satoshi Morita
Masataka Taguri
Katsuaki Tanaka
23 February 2011